Effect of laquinimod on MRI-monitored disease activity in patients with relapsing-remitting multiple sclerosis: a multicentre, randomised, double-blind, placebo-controlled phase IIb study
Author:
G Comi,A Pulizzi,M Rovaris,O Abramsky,T Arbizu,A Boiko,R Gold,E Havrdova,S Komoly,KW Selmaj,B Sharrack,M Filippi
Copyright © 2008 Elsevier Ltd. All rights reserved.